At Equity Pharmaceuticals, we specialize in providing scheduled registered medicines for Gastroenterology, Neurology, Oncology, Infectious Diseases, Chronic Conditions, and Substance Abuse among others.
Our commitment to ethical business practices and zero tolerance for bribery and corruption ensures that we conduct all dealings with integrity.
Equity Section 21 focuses on the import and supply of unlicensed medicines. We manage access to approximately 450 products through Managed Access and Global Access Programs, with the top 150 unlicensed products readily available in our warehouse for immediate patient assistance.
Since 2009, we have been market leaders in unlicensed medicine supply in South Africa, leveraging a vast network of global suppliers and wholesalers to meet urgent medical needs.
At Equity Pharmaceuticals, we value our reputation and we are comitted to conducting our business in an honest and ethical manner.
Click here to send an anonymous report